Extensive alternative splicing in the 5'-untranslated region of the rat and human neuropeptide Y Y5 receptor genes regulates receptor expression

Journal of Neurochemistry

Volumn 73, Issue 3, 1999, Pages 913-920

  Parker, Eric M ^a   Xia, Ling ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Neuropeptide Y; Obesity; Y5 receptor

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA DETERMINATION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TRANSLATION REGULATION;

5' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BRAIN; COS CELLS; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; RADIOLIGAND ASSAY; RATS; RECEPTORS, NEUROPEPTIDE Y; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032873021     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730913.x     Document Type: Article

References (24)

1. Ayoubi T. A. Y. and Van De Yen W. J. M. (1996) Regulation of gene expression by alternative promoters. FASEB J. 10, 453-460.
2. Ball H. J., Shine J., and Herzog H. (1995) Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene. J. Biol. Chem. 270, 27272-27276.
3. Bischoff A., Avramidis P., Erdbrugger W., Munter K., and Michel M. C. (1997) Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br. J. Pharmacol. 120, 1335-1343.
4. Clark J. T., Kalra P. S., Crowley W. R., and Kalra S. P. (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115, 427-429.
5. 5 receptor. J. Clin. Invest. 102, 2136-2145.
6. Gehlert D. R. (1998) Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med. 218, 7-22.
7. Gerald C., Walker M. W., Criscione L., Gustafson E. L., Batzl-Hartmann C., Smith K. E., Vaysse P., Durkin M. M., Laz T. M., Linemeyer D. L., Schaffhauser A. O., Whitebread S., Hofbauer K. G., Taber R. I., Branchek T. A., and Weinshank R. L. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382, 168-171.
8. Gribkoff V. K., Pieschl R. L., Wisialowski T. A., van den Pol A. N., and Yocca F. D. (1998) Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes. J. Neurosci. 18, 3014-3022.
9. Hendry H. C. (1993) Organization of neuropeptide Y neurons in the mammalian central nervous system, in The Biology of Neuropeptide Y and Related Peptides (Colmers W. J. and Wahlestedt C., eds), pp. 65-156. Humana Press, Totowa, New Jersey.
10. Herzog H., Darby K., Ball H., Hort Y., Beck-Sickinger A., and Shine J. (1997) Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation. Genomics 41, 315-319.
11. Hu Y., Bloomquist B. T., Cornfield L. J., DeCarr L. B., Flores-Riveros J. R., Friedman L., Jiang P., Lewis-Higgins L., Sadlowski Y., Schaefer J., Velazquez N., and McCaleb M. L. (1996) Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem. 271, 26315-26319.
12. Marsh D. J., Hollopeter G., Kafer K. E., and Palmiter R. D. (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat. Med. 4, 718-721.
13. McLatchie L. M., Fraser N. J., Main M. J., Wise A., Brown J., Thompson N., Solari R., Lee M. G., and Foord S. M. (1998) RAMPS regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339.
14. Michel M. C., Beck-Sickinger A., Cox H., Doods H. N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. (1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50, 143-150.
15. 1E 5-hydroxytryptamine receptors. J. Neurochem. 67, 2096-2103.
16. 1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur. J. Pharmacol. 349, 97-105.
17. Parola A. L. and Kobilka B. K. (1994) The peptide product of a 5′ leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem. 269, 4497-4505.
18. Schaffhauser A. O., Stricker-Krongrad A., Brunner L., Cumin F., Gerald C., Whitebread S., Criscione L., and Hofbauer K. G. (1997) Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes 46, 1792-1798.
19. Stanley B. G. and Leibowitz S. F. (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 35, 2635-2642.
20. Tang-Christensen M., Kristensen P., Stidsen C. E., Brand C. L., and Larsen P. J. (1998) Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y. J. Endocrinol. 159, 307-312.
21. Wahlestedt C. and Reis D. J. (1993) Neuropeptide Y-related peptides and their receptors-are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol. 32, 309-352.
22. Widdowson P. S. (1997) Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 "feeding" receptor. Brain Res. 758, 17-25.
23. Woldbye D. P., Larsen P. J., Mikkelsen J. D., Klemp K., Madsen T. M., and Bolwig T. G. (1997) Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors. Nat. Med. 3, 761-764.
24. Woldbye D. P., Klemp K., and Madsen T. M. (1998) Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors. J. Pharmacol. Exp. Ther. 284, 633-636.